This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Holger Kubas: Innovator in Pharmaceutical Chemistry
Introduction
Holger Kubas is a notable inventor based in Bad Homburg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds and their therapeutic applications. With a total of 2 patents to his name, Kubas continues to push the boundaries of medical science.
Latest Patents
Kubas's latest patents include groundbreaking work on imidazolonylquinoline compounds and their therapeutic uses. One of his notable inventions focuses on atropisomers, solid forms, salt forms, and deuterated derivatives of the ATM inhibitor 8-(1,3-Dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methyl-1,3-dihydroimidazo[4,5-c]quinolin-2-one. This invention provides stable atropisomers that do not interconvert, represented by specific formulae. Another significant patent relates to a solid pharmaceutical preparation of 3-Fluoro-4-[7-methoxy-3-methyl-8-(1-methyl-1H-pyrazol-4-yl)-2-oxo-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl]-benzonitrile, detailing a method of making the compound and its medical uses.
Career Highlights
Holger Kubas is currently associated with Merck Patent GmbH, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing therapeutic options for various medical conditions. Kubas's dedication to research and development has positioned him as a key figure in his field.
Collaborations
Throughout his career, Kubas has collaborated with esteemed colleagues, including Thomas Fuchss and Axel Becker. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of impactful pharmaceutical solutions.
Conclusion
Holger Kubas exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions through patents and collaborations continue to shape the future of medical treatments. His work not only reflects his expertise but also his commitment to improving healthcare outcomes.